Navigation Links
NIAID to advance B-cell approach to HIV vaccines
Date:5/20/2008

To advance underdeveloped approaches to designing a preventive HIV vaccine, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is launching a new program to foster the study of B cells, immune cells that can produce antibodies with the capacity to neutralize HIV. The $15.6 million, five-year program will strengthen and expand the scientific foundation of HIV vaccine research through a network of 10 research teams nationwide that will share resources, methods and data to accelerate progress.

In the immune system, B cells recognize key parts of microbes, called antigens. Then, in cooperation with T cellsparts of the immune system that kill cells infected by pathogensa reaction is triggered that leads B cells to produce antibodies, which can lock onto antigens and sweep them out of the body. HIV is devilishly good at fooling B cells and shielding itself from antibodies or changing its antigenic parts, so antibodies can rarely rid the body of the virus.

The new NIAID research program aims to uncover mechanisms that will enable scientists to outwit HIV and stimulate the B-cell production of long-lasting antibodies that can neutralize many strains of the virus; such antibodies are known as broadly neutralizing.

This program reflects our commitment to probe the fundamental science underlying HIV vaccine development, says NIAID Director Anthony S. Fauci, M.D. The study of B cells and broadly neutralizing antibodies to HIV will answer pressing, basic scientific questions and bring greater balance to our portfolio of HIV vaccine discovery research.

In recent years, investigator-initiated grants supported by NIAID have focused more heavily on T-cell based approaches to preventive HIV vaccines than on B-cell based ones. Many experts believe a successful HIV vaccine will probably need to activate both T cells and B cells; consequently, NIAIDs creation of the new B-cell research
'/>"/>

Contact: Laura Sivitz
sivitzl@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. NIAID describes research priorities to fight drug-resistant tuberculosis
2. NIAID to convene HIV Vaccine Summit
3. NIAID scientists identify new cellular receptor for HIV
4. NIAID strengthens and expands Vaccine and Treatment Evaluation Units
5. NIAID funds $51M contract to create comprehensive model of immune responses
6. Advances Aid Treatment, Diagnosis of Celiac Disease
7. 2008 American Academy of Pediatric Dentistry Annual Session Highlights Emerging Scientific Advancements
8. Partnerships Effective Communicators of Cancer Advances
9. Partnership of academic centers and community hospitals effective model for disseminating advances
10. THE Aesthetic Show Advances $34 Billion Market
11. Singulex Advances Conversation on Personalized Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... ... July 03, 2015 , ... The Celebrity Dresses is ... dresses similar to those of celebrities will have the opportunity to get 10% discount ... This ensures that people do not have to use coupon codes or remember redemption ...
(Date:7/2/2015)... ... July 02, 2015 , ... Following the recent report by ... obese Americans outnumber merely overweight Americans, Samir Becic emphatically declared a war on obesity ... society right now," Becic said. "We must understand the magnitude of this discovery. For ...
(Date:7/2/2015)... ... ... swing, Americans are flocking to Canada’s many lakes to reel in their fair share of ... it’s easy to understand why. From the Pacific Northwest Coast of British Columbia to the ... huge industry, and Americans make up the vast majority of anglers from outside of Canada. ...
(Date:7/2/2015)... ... July 02, 2015 , ... Get ready to hit ... SOCKS. Since the socks were first introduced, they have rapidly been gaining attention ... inspired four new, fun shades including: blue, lime, pink and red. , ...
(Date:7/2/2015)... CA (PRWEB) , ... July 02, 2015 , ... ActiveBunch.com ... a passion for social fitness. Built to function as a lifestyle community, Active Bunch ... them the opportunity to network, meet, and participate in discussions or group events. ...
Breaking Medicine News(10 mins):Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:ActiveBunch.com Launches as a Social Community for People with Active Lifestyles 2
... High antiretroviral therapy adherence, which has been shown to ... survival, is now associated with lower health care costs, ... of Public Health. Researchers examined the effect of antiretroviral ... that antiretroviral therapy improves health outcomes for people infected ...
... Hopkins University determined that immune responses to the tetanus ... methotrexate (MTX) was compared with MTX alone in patients ... vaccination (Pneumovax pneumonia vaccine), however, were reduced in RA ... are published in the January 2010 issue of ...
... recent evaluation by the Centre for Addiction and Mental Health ... be effective in changing drinking behaviours and offers a significant ... its kind, the study published in Addiction found ... reduced their alcohol consumption by 30% - or six to ...
... in prostate cancer patients receiving external beam radiation therapy ... but then stabilizes and does not continuously decline as ... January 1 issue of the International Journal of ... Society for Radiation Oncology (ASTRO). Prostate cancer is ...
... a multi-bed hospital room dramatically increases the risk of acquiring ... A new study led by infectious diseases expert Dr. Dick ... C. difficile ( Clostridium difficile ) rises with ... in a two, three or four-bedded room, each time you ...
... EDITOR,S PICK: Depleting breast cancerinitiating cells by targeting the ... many types of cancer, including breast cancer, are initiated ... the tumor known as cancer stem cells. These cells ... and recurrence after treatment, meaning that many researchers are ...
Cached Medicine News:Health News:High antiretroviral therapy adherence associated with lower health care costs 2Health News:Immune responses to tetanus vaccine unchanged for RA patients on rituximab 2Health News:Technology new gateway into treatment for problem alcohol users: Study 2Health News:Sexual function does not continuously decline after radiation therapy treatments for prostate cancer 2Health News:Sharing a hospital room increases risk of 'super bugs' 2Health News:JCI online early table of contents: January 4, 2009 2Health News:JCI online early table of contents: January 4, 2009 3Health News:JCI online early table of contents: January 4, 2009 4
(Date:7/3/2015)... 3, 2015  Obsidian HDS, the developer of PharmaShine ... for the management of data on pharmaceutical and device ... now includes the 2014 Open Payments General and Research ... June 30. The data disclosed on Open Payments for ... and providers totaling $6.49 billion and is the largest ...
(Date:7/2/2015)... HILL, N.C. , July 2, 2015 /PRNewswire/ ... own employees to capture critical product and market ... are many benefits to employee-based studies, it is ... leverage their own internal employees to capture critical ... study by benchmarking firm, Best Practices, LLC, most ...
(Date:7/2/2015)... Fla. , July 2, 2015  Fort ... is pleased to announce that its Consumer Group ... Beverages") to Kerry Group plc (ISE: KRZ) ("Kerry"), ... taste and nutrition systems, as well as functional ... and pharmaceutical markets. Farlie Turner served as the ...
Breaking Medicine Technology:New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2Leveraging Employee Insights to Produce Cutting-Edge Market Research 2Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
... PulseOx 5500TM is the worlds first ... saturation and heart rate to use ... 5500TM uses SPO Medicals patented technology ... is more usable for many patients ...
All-in-One Fingertip Oximeter...
The reliable and easy-to-use 3900/P pulse oximeter is now more advanced - featuring TruTrak+ technology, the proprietary clinical motion algorithm from Datex+-Ohmeda....
Medicine Products: